文献速递癫痫

Na+通道抑制剂如何改善Lennox-Gastaut综合征的癫痫发作

How Can an Na+ Channel Inhibitor Ameliorate Seizures in Lennox-Gastaut Syndrome?
PubMed 文献 · Ann Neurol · 2021-04-09

研究通过天然神经元和哺乳动物癫痫模型定量比较鲁非酰胺与其他Na+通道抑制剂的结合动力学和抗癫痫效果。鲁非酰胺对失活Na+通道结合速率远快于苯妥英,对短爆发伴超极化间歇的放电(如棘慢波放电)有效,并在戊四氮或AY-9944模型中抑制棘慢波相关发作,而苯妥英无效。结论提示应根据放电特征和药物分子药理学合理选择抗癫痫药。

要点

  • 鲁非酰胺对失活Na+通道结合速率快于苯妥英,可抑制短爆发性放电。
  • 鲁非酰胺在戊四氮或AY-9944模型中抑制棘慢波相关发作,苯妥英无效。
  • 间歇期超极化不明显时苯妥英可能更优,因其亲和力更高。

核心结论

  • Na+通道抑制剂需足够快结合才能在短爆发期间起效并抑制棘慢波放电,鲁非酰胺在此类情况下更优。

研究设计与样本

  • 在天然神经元和哺乳动物癫痫模型中定量表征鲁非酰胺对Na+通道、细胞放电和癫痫行为的影响,并与其它Na+通道抑制剂比较。

主要发现

  • 鲁非酰胺对失活Na+通道的结合速率远快于苯妥英。
  • 鲁非酰胺对短爆发伴超极化间歇的放电(如棘慢波放电)有独特效果。
  • 鲁非酰胺在戊四氮或AY-9944模型中抑制棘慢波相关发作,苯妥英无效。
  • 苯妥英在间歇期超极化不明显时可能更优,因其亲和力更高。

临床怎么用

  • 根据发作期放电特征和Na+通道抑制剂的结合动力学与亲和力合理选择抗癫痫药。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Lennox-Gastaut syndrome (LGS) is an epileptic encephalopathy frequently associated with multiple types of seizures. The classical Na+ channel inhibitors are in general ineffective against the seizures in LGS. Rufinamide is a new Na+ channel inhibitor, but approved for the treatment of LGS. This is not consistent with a choice of antiseizure drugs (ASDs) according to simplistic categorical grouping. METHODS: The effect of rufinamide on the Na+ channel, cellular discharges, and seizure behaviors was quantitatively characterized in native neurons and mammalian models of epilepsy, and compared with the other Na+ channel inhibitors. RESULTS: With a much faster binding rate to the inactivated Na+ channel than phenytoin, rufinamide is distinctively effective if the seizure discharges chiefly involve short bursts interspersed with hyperpolarized interburst intervals, exemplified by spike and wave discharges (SWDs) on electroencephalograms. Consistently, rufinamide, but not phenytoin, suppresses SWD-associated seizures in pentylenetetrazol or AY-9944 models, which recapitulate the major electrophysiological and behavioral manifestations in typical and atypical absence seizures, including LGS. INTERPRETATION: Na+ channel inhibitors shall have sufficiently fast binding to exert an action during the short bursts and then suppress SWDs, in which cases rufinamide is superior. For the epileptiform discharges where the interburst intervals are not so hyperpolarized, phenytoin could be better because of the higher affinity. Na+ channel inhibitors with different binding kinetics and affinity to the inactivated channels may have different antiseizure scope. A rational choice of ASDs according to in-depth molecular pharmacology and the attributes of ictal discharges is advisable. ANN NEUROL 2021;89:1099-1113.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Lin YC, Lai YC, Chou P, et al. How Can an Na+ Channel Inhibitor Ameliorate Seizures in Lennox-Gastaut Syndrome? Ann Neurol. 2021. PMID: 33745195. doi:10.1002/ana.26068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。